Aug 10 (Reuters) - Moody's on Valeant Pharmaceuticals (NYSE:VRX) VRX.TO -
* Moody's: Valeant's proposed amendment is positive for liquidity
* There is no impact on Valeant's ratings including the B2 corporate family rating or the negative rating outlook Source text for Eikon: Further company coverage: VRX.TO